BMJ 1994;309:194 (16 July)

Letters

Antenatal screening for syphilis Is not justified

EDITOR, - In these heady days of cost effective health care, priority setting, and market forces, I felt as though I was back in the 1970s while reading Angus Nicoll and Clare Moisley's editorial on antenatal screening for syphilis.1 They describe a routine test that is extensively carried out to prevent a condition whose true incidence is unknown. It is all very well applauding new surveillance initiatives, but isn't it surprising that these were not started some years go? There is no mention at all of the costs of the tests in Britain, let alone whether the tests are cost effective. Screening for some conditions - for example, cholesterol testing - has moved focus recently from general screening to the targeting of high risk populations. If we accept that congenital syphilis may increase in Britain (as it has done in the United States) has any consideration been given to offering . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Antenatal screening for syphilis
A Nicoll and C Moisley
BMJ 1994 308: 1253-1254. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ